Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts

  • Neiltje
    replied
    Originally posted by GenoMax View Post
    I assume the quote you included is referring to doing the post-run analysis on the MiSeq itself (http://supportres.illumina.com/docum...15042320_a.pdf).

    You strictly do not need to use the analysis provided on the instrument (or in BaseSpace). If you do not have physical access to MiSeq your sequence provider will have to actually run this analysis workflow for you.
    We decided not to use this because we have a bioinformatics team. Thanks for your answer!

    Leave a comment:


  • GenoMax
    replied
    I assume the quote you included is referring to doing the post-run analysis on the MiSeq itself (http://supportres.illumina.com/docum...15042320_a.pdf).

    You strictly do not need to use the analysis provided on the instrument (or in BaseSpace). If you do not have physical access to MiSeq your sequence provider will have to actually run this analysis workflow for you.

    Leave a comment:


  • Neiltje
    started a topic small RNA seq question Miseq

    small RNA seq question Miseq

    Hi,

    I'm new in sequencing, next week I'm going to prepare a small RNA library using NEBNExt Multiplex small RNA prep kit for Illumina from New England biolabs.
    I'm watching some tutorials from Illumina and I'm stumbling on this:

    Workflow: small RNA
    What's It's Used For: Sequencing of cDNA following reverse transcription of small RNA. Annotation backed by mirBase and Rfam. Requires contaminants, RNA, and miRNA FASTA files, in addition to the reference genome. (Human genome is included on MiSes.) FASTQ files and stats files are available for subsequent downstream analysis.


    I don't see any requirements for all the other workflows, why does this workflow need one? And where do I get that information?

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
46 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
46 views
0 reactions
Last Post SEQadmin2  
Working...